GILD Archives

Gilead Sciences: Strategic Gains From Lenacapavir And Trodelvy Justify A Buy Rating (GILD)Gilead Sciences: Strategic Gains From Lenacapavir And Trodelvy Justify A Buy Rating (GILD)

June 24, 2024 Stephen Ayers 0 Comments 1:41 pm

mouu007Overview I last looked at Gilead Sciences (NASDAQ:GILD) in February, following their acquisition of liver disease developer CymaBay Therapeutics. I[...]

Dividend Champion, Contender, And Challenger Highlights: Week Of June 23Dividend Champion, Contender, And Challenger Highlights: Week Of June 23

June 23, 2024 Justin Law 0 Comments 1:01 pm

Dividend Champion, Contender, And Challenger Highlights: Week Of June 23 Buy cryptocurrency Source link Refer And Earn Demat Account –[...]

Gilead Stock: Records Positive Phase III Results In HIV (NASDAQ:GILD)Gilead Stock: Records Positive Phase III Results In HIV (NASDAQ:GILD)

June 22, 2024 Brendan O'Boyle 0 Comments 7:56 am

Gilead Sciences, Foster City, CA Tomsmith585/iStock Unreleased via Getty ImagesGilead Sciences (NASDAQ:GILD) on Thursday announced positive topline results from an[...]

Eli Lilly: The Party Is Probably Nearing The End (NYSE:LLY)Eli Lilly: The Party Is Probably Nearing The End (NYSE:LLY)

June 19, 2024 ALLKA Research 0 Comments 4:30 pm

Eli Lilly: The Party Is Probably Nearing The End Buy cryptocurrency Source link Refer And Earn Demat Account – Get[...]

Category: GILD